Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - sumatriptan succinate 140mg equivalent to 100 mg sumatriptan base;   - tablet - 100 mg - active: sumatriptan succinate 140mg equivalent to 100 mg sumatriptan base   excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opaspray white m-1-7120 purified water - imigran tablets are indicated for the acute relief of migraine attacks with or without aura in adults aged 18 to 65 years.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - sumatriptan succinate 70mg equivalent to 50 mg sumatriptan base;   - tablet - 50 mg - active: sumatriptan succinate 70mg equivalent to 50 mg sumatriptan base   excipient: croscarmellose sodium lactose lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink ys-1-1441-g purified water - imigran tablets are indicated for the acute relief of migraine attacks with or without aura in adults aged 18 to 65 years.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 100mg - chewable/dispersible tablet - 100 mg - active: lamotrigine 100mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 200mg;   - chewable/dispersible tablet - 200 mg - active: lamotrigine 200mg   excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 25mg - chewable/dispersible tablet - 25 mg - active: lamotrigine 25mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 2mg - chewable/dispersible tablet - 2 mg - active: lamotrigine 2mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - bipolar disorder (adults 18 years of age and over) lamictal is indicated for the prevention of mood episodes in patients with bipolar disorder, predominantly by preventing depressive episodes.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 50mg - chewable/dispersible tablet - 50 mg - active: lamotrigine 50mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamotrigine 5mg - chewable/dispersible tablet - 5 mg - active: lamotrigine 5mg excipient: aluminium magnesium silicate blackcurrant flavour 502009 ap0551 calcium carbonate hyprolose magnesium stearate povidone saccharin sodium sodium starch glycolate - epilepsy adults (over 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with lennox-gastaut syndrome. children (2 to 12 years of age) lamictal is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with lennox-gaustaut syndrome.

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - atovaquone 250mg; proguanil hydrochloride 100mg - film coated tablet - 250mg/100mg - active: atovaquone 250mg proguanil hydrochloride 100mg excipient: hyprolose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose opadry pink oy-s-24972 poloxamer 188 povidone sodium starch glycolate

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - atovaquone 62.5mg; proguanil hydrochloride 25mg - film coated tablet - 62.5mg/25mg - active: atovaquone 62.5mg proguanil hydrochloride 25mg excipient: ethanol hyprolose macrogol 400 macrogol 8000 magnesium stearate microcrystalline cellulose opadry pink oy-s-24972 poloxamer 188 povidone purified water   sodium starch glycolate